Pharma Focus Asia offers the most advanced strategies in Pharmaceutical Sector, the most significant developments in the industry and provides information on the latest research in Pharma Healthcare. The following Press Releases highlights the recent happenings in the Pharmaceutical Sector across the world.
BEIJING Aug 23 2016 PRNewswire Sinovac Biotech Ltd NASDAQ SVA a leading provider of biopharmaceutical products in China announced today its unaudited second quarter ended June 30 2016 Mr Weidong Yin Chairman President and CEO of the Sinovac commented As forecasted on our first quarter earnings ..
NEW BRUNSWICK NJ Aug 22 2016 PRNewswireUSNewswire To further its mission of advancing healthrelated educational programs in the state New Jersey Health Foundation NJHF has once again contributed 100000 to fund Student Summer Research Programs at Rowan and Rutgers Universities To date NJHF has con..
LOS ANGELES Aug 22 2016 PRNewswire Drugstore News recently reported research about the growth of the natural overthecounter OTC medicine market indicating the market for natural OTCs increased by more than 11 percent in 2015 It reports that the largest category the natural coughcoldimmunity marke..
XIANYANG China Aug 22 2016 PRNewswire Biostar Pharmaceuticals Inc NASDAQ BSPM Biostar or the Company a PRCbased manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions today announced its financial results for the second quarter..
SAN DIEGO and VANCOUVER British Columbia Aug 22 2016 PRNewswire Sophiris Bio Inc NASDAQ SPHS Sophiris a biopharmaceutical company developing PRX302 topsalysin for the treatment of urological diseases today announced that it intends to offer and sell subject to market and other conditions its commo..
SAN FRANCISCO Aug 22 2016 PRNewswire Kindred Biosciences Inc NASDAQ KIN a biopharmaceutical company focused on saving and improving the lives of pets today announced the submission of the Effectiveness Technical Section of the New Animal Drug Application for Mirataz mirtazapine transdermal ointme..
SEATTLE Aug 22 2016 PRNewswire PhaseRx Inc NASDAQ PZRX a biopharmaceutical company developing mRNA products to correct lifethreatening inherited liver diseases in children today announced the appointment of Peggy Phillips to the companys board of directors Ms Phillips will be replacing Richard Ul..
HONG KONG Aug 22 2016 PRNewswire China Cord Blood Corporation NYSE CO CCBC or the Company Chinas leading provider of cord blood collection laboratory testing hematopoietic stem cell processing and stem cell storage services today announced its unaudited financial results for the first quarter of ..
LONDON Aug 22 2016 PRNewswire International private equity firm Cinven today announces that it has agreed to acquire Bioclinica a global provider of clinical trial services and technology to contract research organizations CROs and pharmaceutical companies based in Pennsylvania from Water Str..
OAKVILLE ON Aug 22 2016 PRNewswire Concordia International Corp Concordia or the Company NASDAQ CXRX TSX CXR an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs stated that Concordias Chairman and Chief Executive Officer Mark Thompson was notified ear..
CHESTERFIELD United Kingdom Aug 22 2016 PRNewswire Mallinckrodt Pharmaceuticals NYSE MNK a leading global specialty pharmaceutical company will present on Monday Sept 12 2016 at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt New York 109 E 42nd St New York Mark Trudeau Presi..
NEW YORK August 22 2016 PRNewswire StockCallerscom today has issued research reports on PTC Therapeutics Inc NASDAQ PTCT Grifols SA NASDAQ GRFS Puma Biotechnology Inc NYSE PBYI and 22nd Century Group Inc NYSE MKT XXII These stocks belong in the Biotech arena which over the recent weeks has slowl..
CINCINNATI Aug 22 2016 PRNewswire BioRx a Diplomat company NYSE DPLO announced today the release of its newest version of the MyFactor app for iOS and Android mobile devices The new versions of the app are available for download on the App Store and Google Play MyFactor enables hemophilia patien..
SAN DIEGO Aug 22 2016 PRNewswire MabVax Therapeutics Holdings Inc Nasdaq MBVX a clinicalstage oncology drug development company announces the closing of its public offering of common stock and Series F Preferred Stock and warrants for a total of 94 million including approximately 800000 received f..
NEW YORK and ANN ARBOR Mich Aug 22 2016 PRNewswire Lycera Corp a privately held biopharmaceutical company developing breakthrough immune modulatory medicines announced today the initiation of a Phase 2 clinical trial of the Companys lead clinicalstage candidate LYC30937Enteric Coated in patients w..
RARITAN NJ Aug 22 2016 PRNewswire Janssen Pharmaceuticals Inc today announced that 25 abstracts have been accepted for presentation by Janssen and its development partner Bayer at the ESC Congress 2016 taking place August 2731 in Rome Italy New realworld evidence from the EXPLORER research progra..
RALEIGH NC Aug 22 2016 PRNewswire Ateb Inc the industrys leading provider of pharmacybased patient care solutions completes the expansion of its Raleigh Headquarters as a result of the companys continued growth Generating an additional 25 percent growth in the companys overall head count in the ..
HAYWARD Calif Aug 22 2016 PRNewswire Impax Laboratories Inc NASDAQ IPXL announcedtoday that Richard A Bierly was appointed to the Impax Board of Directors on August 19 and will also serve on the Boards Audit Committee Mr Bierly 61 was most recently the Chief Financial Officer of Medivation Inc L..
MENLO PARK Calif Aug 22 2016 PRNewswire BioPharmX Corporation NYSE MKT BPMX a specialty pharmaceutical company developing products for the dermatology market today released final findings from its Phase 2a safety study of BPX01 that show the unique topical gel formulation of minocycline reduced f..
WOONSOCKET RI Aug 22 2016 PRNewswire A new study from the CVS Health Research Institute found that interventions to keep patients with common chronic conditions adherent is extraordinarily costeffective The study published today in The American Journal of Managed Care also found an even greater op..